Lumida
/IJT
⌘K
IJT

IJT

IJT
$166.46USD+0.48%+0.79 today

MARKET CAP

0

P/E (TTM)

FWD P/E

DAY RANGE

$166 – $168

52W RANGE

$133
$180

AI Summary

Stalk
StalkMedium

IJT remains in a bullish medium-term environment, supported by its overall uptrend and price above the 50-day and 200-day moving averages. Recent pullback into the short-term EMAs reflects consolidation after an advance, offering a potential entry zone near the sliding 9/20 EMA support. Overbought/oversold context is neutral, requiring a clear acceptance in the EMA region before committing. Medium-term structure remains constructive in Stage 2, favoring deferred bullish engagement at support. Key risk is a breakdown below the 9/20 EMA that could signal deeper correction toward the 50-day SMA.

  • Protagonist Therapeutics returned to profitability and raised FY guidance.
  • Fed pause prospects lower Treasury yields, easing small-cap borrowing costs.
  • IJT is exposed to volatile small-cap swings amid geopolitical tensions.
Full analysis →
Insider Trades0 trades
No trades match the current filters